NCT00206557View on ClinicalTrials.gov

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

April 30, 2007

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Interventions
DRUG

Raloxifene

DRUG

Estradiol/dyhydroprogestrone

Trial Locations (1)

3181

Alfred Psychiatry Research Centre, Alfred Hospital, Melbourne

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

The Alfred

OTHER

NCT00206557 - The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study | Biotech Hunter | Biotech Hunter